Biomarker: E209-IgE Gerbil Epithelium

Overview

E209-IgE Gerbil Epithelium measures serum immunoglobulin E (IgE) antibodies directed against proteins from gerbil epithelium, including material associated with skin, fur, and dander. Gerbil allergens can trigger IgE-mediated immediate hypersensitivity, with symptoms such as allergic rhinitis, asthma, or skin reactions after exposure. A detectable or elevated result indicates sensitization and may support gerbil allergy when consistent with the patient’s exposure history and symptoms, but it does not independently establish clinical allergy or predict symptom severity. The test may help identify gerbil epithelium as a relevant allergen in patients with suspected pet-related or occupational allergy.

Clinical Use Cases

Support evaluation of suspected gerbil-associated allergic rhinitis, asthma, or other immediate hypersensitivity reactions.
Identify gerbil epithelium as a possible allergen when symptoms occur after handling gerbils or exposure to their housing environment.
Help investigate occupational allergy in laboratory, veterinary, or animal-care settings.
Complement the clinical history and, when appropriate, skin-prick testing.
Assist with allergen identification when considering exposure avoidance or specialist-directed allergy management.
Help evaluate suspected animal-related asthma or rhinitis, which has been documented in human case reports involving gerbil exposure.

Specimen Types

Serum, typically collected from venous blood.

Measurement Methods

Fluorescence enzyme immunoassay (FEIA) using an allergen-specific solid phase, such as an ImmunoCAP system.
Historically, radioallergosorbent testing (RAST) has been used to detect gerbil-specific IgE in clinical reports.
Results are generally reported as allergen-specific IgE concentration in kU/L and may include an interpretive class.

Test Preparation and Influencing Factors

Fasting is generally not required for serum-specific IgE testing.
Antihistamines usually do not interfere with blood-specific IgE testing, although medication instructions should be confirmed with the ordering clinician or laboratory.
The result should be interpreted with the timing, intensity, and type of gerbil exposure, as well as the patient’s symptoms.
Detectable specific IgE may reflect sensitization without clinically significant disease.
Markedly elevated total IgE may contribute to nonspecific binding and false-positive specific IgE results.
Recent exposure is not generally required for testing, and treatment should not be changed solely on the basis of the result.
Collection, storage, and handling requirements depend on the performing laboratory.